Neonatal outcomes and follow-up of children born to women with pregnancy-associated cancer: a prospective observational study.
Michele Antonio CapozzaAlberto RomanoStefano MastrangeloGiorgio AttinàPalma MauriziSimonetta CostaGiovanni VentoGiovanni ScambiaAntonio RuggieroPublished in: BMC pregnancy and childbirth (2024)
PAC treatment during the second or third trimester does not seem to be dangerous for the fetus, however infants born from PAC must be carefully evaluated for to rule out the consequences of chemotherapy and exclude the presence of metastasis. Long-term follow-up, especially in children exposed to chemotherapy, should be encouraged to obtain relevant data on long-term toxicity.
Keyphrases
- gestational age
- preterm birth
- young adults
- locally advanced
- low birth weight
- electronic health record
- oxidative stress
- squamous cell carcinoma
- metabolic syndrome
- preterm infants
- type diabetes
- squamous cell
- pregnant women
- adipose tissue
- data analysis
- chemotherapy induced
- insulin resistance
- artificial intelligence
- replacement therapy
- glycemic control
- smoking cessation